See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597264_2017_Blueprint_Medicines_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss': 9, '00200 - Statement - Statements of Operations (Calc2)': 2}} |
Graph
Absolute values for 0001597264, Blueprint Medicines Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 220,425,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,188,000 |
| 3 | remainder_Assets | 56,182,000 |
| 4 | LiabilitiesCurrent | 28,512,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,218,000 |
| 9 | ResearchAndDevelopmentExpense | 81,131,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 27,772,000 |
| 12 | remainder_NetIncome | 82,000 |
| 13 | remainder_ComprehensiveNetIncome | -18,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 282,795,000 |
| 1 | Liabilities | 28,512,000 |
| 2 | Expenses | 100,349,000 |
| 3 | Revenues | 27,772,000 |
| 4 | StockholdersEquity | 254,283,000 |
| 5 | NetIncome | -72,495,000 |
| 6 | ComprehensiveNetIncome | -72,504,000 |
| 7 | BaseVar | 219,764,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.10 |
| 9 | EconomicCapitalRatio | 3.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
